Bruker Statistics
Total Valuation
Bruker has a market cap or net worth of $9.36 billion. The enterprise value is $10.96 billion.
| Market Cap | 9.36B |
| Enterprise Value | 10.96B |
Important Dates
The last earnings date was Wednesday, November 4, 2026, before market open.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | Sep 21, 2026 |
Share Statistics
Bruker has 152.72 million shares outstanding. The number of shares has increased by 0.38% in one year.
| Current Share Class | 152.36M |
| Shares Outstanding | 152.72M |
| Shares Change (YoY) | +0.38% |
| Shares Change (QoQ) | +0.13% |
| Owned by Insiders (%) | 31.82% |
| Owned by Institutions (%) | 94.11% |
| Float | 103.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 26.15 |
| PS Ratio | 2.67 |
| Forward PS | 2.57 |
| PB Ratio | 4.05 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 38.26 |
| P/OCF Ratio | 27.39 |
| PEG Ratio | 5.27 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.98, with an EV/FCF ratio of 44.78.
| EV / Earnings | n/a |
| EV / Sales | 3.12 |
| EV / EBITDA | 19.98 |
| EV / EBIT | 34.26 |
| EV / FCF | 44.78 |
Financial Position
The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.73.
| Current Ratio | 1.84 |
| Quick Ratio | 0.58 |
| Debt / Equity | 0.73 |
| Debt / EBITDA | 2.83 |
| Debt / FCF | 7.00 |
| Interest Coverage | 8.02 |
Financial Efficiency
Return on equity (ROE) is -4.79% and return on invested capital (ROIC) is 7.95%.
| Return on Equity (ROE) | -4.79% |
| Return on Assets (ROA) | 3.26% |
| Return on Invested Capital (ROIC) | 7.95% |
| Return on Capital Employed (ROCE) | 6.87% |
| Weighted Average Cost of Capital (WACC) | 9.77% |
| Revenue Per Employee | $316,924 |
| Profits Per Employee | -$15,092 |
| Employee Count | 11,085 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 1.57 |
Taxes
In the past 12 months, Bruker has paid $42.30 million in taxes.
| Income Tax | 42.30M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +52.51% in the last 52 weeks. The beta is 1.27, so Bruker's price volatility has been higher than the market average.
| Beta (5Y) | 1.27 |
| 52-Week Price Change | +52.51% |
| 50-Day Moving Average | 59.01 |
| 200-Day Moving Average | 50.44 |
| Relative Strength Index (RSI) | 53.94 |
| Average Volume (20 Days) | 2,541,735 |
Short Selling Information
The latest short interest is 12.67 million, so 8.30% of the outstanding shares have been sold short.
| Short Interest | 12.67M |
| Short Previous Month | 12.41M |
| Short % of Shares Out | 8.30% |
| Short % of Float | 12.22% |
| Short Ratio (days to cover) | 5.27 |
Income Statement
In the last 12 months, Bruker had revenue of $3.51 billion and -$167.30 million in losses. Loss per share was -$1.10.
| Revenue | 3.51B |
| Gross Profit | 1.71B |
| Operating Income | 319.80M |
| Pretax Income | -73.40M |
| Net Income | -167.30M |
| EBITDA | 548.30M |
| EBIT | 319.80M |
| Loss Per Share | -$1.10 |
Balance Sheet
The company has $119.70 million in cash and $1.71 billion in debt, with a net cash position of -$1.59 billion or -$10.44 per share.
| Cash & Cash Equivalents | 119.70M |
| Total Debt | 1.71B |
| Net Cash | -1.59B |
| Net Cash Per Share | -$10.44 |
| Equity (Book Value) | 2.34B |
| Book Value Per Share | 15.12 |
| Working Capital | 985.00M |
Cash Flow
In the last 12 months, operating cash flow was $341.80 million and capital expenditures -$97.10 million, giving a free cash flow of $244.70 million.
| Operating Cash Flow | 341.80M |
| Capital Expenditures | -97.10M |
| Depreciation & Amortization | 228.50M |
| Net Borrowing | -216.50M |
| Free Cash Flow | 244.70M |
| FCF Per Share | $1.60 |
Margins
Gross margin is 48.67%, with operating and profit margins of 9.10% and -3.51%.
| Gross Margin | 48.67% |
| Operating Margin | 9.10% |
| Pretax Margin | -2.09% |
| Profit Margin | -3.51% |
| EBITDA Margin | 15.61% |
| EBIT Margin | 9.10% |
| FCF Margin | 6.97% |
Dividends & Yields
This stock pays an annual dividend of $0.20, which amounts to a dividend yield of 0.33%.
| Dividend Per Share | $0.20 |
| Dividend Yield | 0.33% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | 12.48% |
| Buyback Yield | -0.38% |
| Shareholder Yield | -0.05% |
| Earnings Yield | -1.80% |
| FCF Yield | 2.61% |
Analyst Forecast
The average price target for Bruker is $67.33, which is 9.82% higher than the current price. The consensus rating is "Buy".
| Price Target | $67.33 |
| Price Target Difference | 9.82% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | 4.33% |
| EPS Growth Forecast (3Y) | 15.03% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |